Christopher D. Maggiore - 01 Aug 2022 Form 4 Insider Report for Zivo Bioscience, Inc. (ZIVO)

Role
Director, 10%+ Owner
Signature
/s/ Christopher D. Maggiore
Issuer symbol
ZIVO
Transactions as of
01 Aug 2022
Net transactions value
$0
Form type
4
Filing time
01 Aug 2022, 16:22:48 UTC
Previous filing
08 Dec 2022
Next filing
14 Feb 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZIVO Nonstatutory Stock Option to Purchase Common Stock Award $0 +15,797 $0.000000 15,797 08 Jul 2022 Common Stock 15,797 $3.61 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was issued pursuant to the 2021 Equity Incentive Plan and vests as follows: 25% on the first three 3-month anniversaries of the grant, and 25% on the day prior to the Company's 2023 Annual Meeting of Stockholders, subject to the reporting person's continuous service on each applicable vesting date.